Fabros, Loreta .

HRN: 23-01-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/06/2023
06/13/2023
TOPICAL
1%
TID
Decubitus Ulcer
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: